Concepedia

Publication | Open Access

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

DOIFull Paper Access

39

Citations

31

References

2023

Year

Richard Cathomas, Sacha I. Rothschild, Stefanie Hayoz, Lukas Bubendorf, Berna C. Özdemir, Bernhard Kiss, Andreas Erdmann, Stefanie Aeppli, Nicolas Mach, Räto T. Strebel,
Journal of Clinical Oncology

Abstract

The addition of perioperative durvalumab to the standard of care for patients with resectable MIUC results in a high EFS and OS at 2 years.

References

YearCitations

Page 1